We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alessio Fasano

Alessio Fasano MD

W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of the Division of Pediatric Gastroenterology and Nutrition, Associate Chief, Department of Pediatrics, Basic, Clinical and Translational Research, Director of the Center for Celiac Research and Treatment, Director of the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA

Dr. Fasano is Professor of Pediatrics at Harvard Medical School and Director of the Center for Celiac Research and Treatment and the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital in Boston, Mass. He is a pioneer in the recognition and treatment of celiac disease and other gluten-related disorders. His current research encompasses basic science focused on bacterial pathogenesis, the composition of the gut microbiome and its function in health and disease, the regulation of gut permeability, and intestinal mucosal biology and immunology, as well as translational science focused on the role of impaired intestinal barrier function in the pathogenesis of autoimmune and inflammatory diseases, including celiac disease and type 1 diabetes. 

Disclosures

Disclosure: Dr. Fasano is a co-founder and stockholder of Alba Therapeutics.